University of Maryland

IN VITRO DIAGNOSTICS Alliances Oxford Immunotec Global PLC Qiagen NV Oxford Immunotec Global PLC and Qiagen NV have settled patent infringement litigation surrounding Qiagen's QuantiFERON-TB

Biopharmaceutical start-up companies – firms founded four years ago or less – raised fewer dollars during the third quarter than during the prior quarter despite Roivant Sciences GMBH 's massive $1

Every missive, every map and model, on the evolving landscape of personalized medicine puts the patient at the center. Yet it’s surprising that many patient advocates don’t feel their perspective is a

In the billion dollar market for radiotherapy products, pencil beam proton therapy is emerging as a promising technology that could potentially revolutionize cancer care. The technology is very expens